quantum-dots
(2)
Aihua Fu
Aihua Fu is a nanobiotechnologist and the co-founder, President and CEO of NVIGEN Inc., a San Jose nanobiotechnology company building molecularly engineered magnetic and fluorescent nanoparticles for cancer detection and personalized medicine. Trained as a chemist under Nobel-track nanoscience pioneer A. Paul Alivisatos at UC Berkeley and as a postdoc at Stanford, she turned quantum-dot and magnetic-bead research into commercial tools for liquid biopsy, cfDNA extraction, single-cell sequencing and circulating tumor cell capture. Her flagship NVIGEN X and NERNST-Seq platforms aim to read DNA, RNA, protein and cell signals together to predict cancer recurrence early and guide therapy.
Martin Devenney
Dr. Martin Devenney is the CEO of Nanosys, the world's leading quantum dot technology company now part of Shoei Chemical. A chemist-turned-manufacturer with a PhD from Queen's University Belfast and over 35 patents, he spent eight years scaling Nanosys's quantum dot production from lab curiosity to the backbone of more than 1,000 unique display products across 70 million consumer devices. Named CEO in May 2023, he then engineered the company's acquisition by Japanese chemical giant Shoei Chemical in September 2023, positioning Nanosys to lead the next generation of display technologies including NanoLED, QD-OLED, and automotive quantum dot applications.